Regenxbio Inc (FRA:RB0)
€ 7.05 0 (0%) Market Cap: 350.57 Mil Enterprise Value: 186.24 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 59/100

Q3 2024 Regenxbio Inc Earnings Call Transcript

Nov 06, 2024 / 09:30PM GMT
Release Date Price: €8.1 (+2.53%)
Operator

Welcome everyone to the Q3 2024 Regenxbio Earnings conference call. At this time, all participants are on a listen-only mode. After the speaker presentation, there will be a question and answer session to ask a question. During the session. You will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised to withdraw your question. Please press star 11 again. Please be advised that today's conference is being recorded at this time. I'd like to turn the conference over to Patrick Christmas, Chief Legal Officer of Regenxbio. Please go ahead.

Patrick Christmas
Regenxbio Inc - Executive Vice President, Chief Legal Officer

Good afternoon and thank you for joining us today. Earlier this afternoon, Regenxbio released financial and operating results for the third quarter ended September 30th 2024. The press release is available on our website at www.regenxbio.com. Today's conference call will include forward-looking statements regarding our financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot